A paradigm for Africa-centric vaccine development in Equatorial Guinea

The Equatorial Guinea Malaria Vaccine Initiative (EGMVI) highlights how long-term African government and international energy industry investment, plus novel partnerships, can enable clinical development of vaccines in Africa, for Africa. We review achievements and challenges of this pioneering, award -winning, public-private partnership which offers a model for future Africa -centric clinical research and development (R&D).